Peripheral Venous Catheter Growth Analysis & Future Outlook 2033

Peripheral Venous Catheter by Application (Hospital, Ambulatory Surgery Center), by Types (Temporary Catheter, Short-term Catheter, Long term Catheter), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Peripheral Venous Catheter Market Overview

A Peripheral Venous Catheter (PVC) is a short, flexible tube inserted into peripheral veins to deliver fluids, medications, or to draw blood. Its widespread use across acute, ambulatory, and home‑care settings makes it a cornerstone of modern infusion therapy. The Peripheral Venous Catheter market size was approximately $4.5 billion in 2025, and the market forecast projects it to reach $7.2 billion by 2033, delivering a compound annual growth rate (CAGR) of roughly 6.2% during the 2026‑2033 horizon. This growth outlook is propelled by aging populations, rising chronic disease prevalence, and expanding outpatient procedures, while industry expansion is further accelerated by advancements in catheter materials, antimicrobial coatings, and minimally invasive insertion technologies.

Loading chart…

Three pivotal forces shape the PVC landscape: (1) technological innovation—antimicrobial and heparin‑bonded catheters reduce infection risk, driving premium adoption; (2) regulatory momentum—stricter infection‑control guidelines in North America and Europe compel hospitals to upgrade inventory; and (3) supply‑chain resilience—localized manufacturing in Asia‑Pacific mitigates disruptions and fuels cost‑competitiveness. North America remains the largest market, anchored by the United States’ extensive hospital network, while Asia‑Pacific emerges as the fastest‑growing region, propelled by rapid healthcare infrastructure expansion in China and India. Executives should monitor these dynamics to align product portfolios and investment strategies with the evolving global demand.

Report Overview

Report Attribute	Details
Market size value in 2025	2.80 billion
Revenue forecast in 2033	4.74 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GaltNeedleTech; Hospira; Vigmed; B. Braun Melsungen; C.R. Bard; BD Medical; Vygon; Smiths Medical; Teleflex; Shanghai Puyi Medical Instruments; Terumo Medical; Medline Industries; Retractable Technologies; Dukwoo Medical; NIPRO Medical; MVM Life Science Partners
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Peripheral Venous Catheter market is at a strategic inflection point, driven by aging demographics, expanding outpatient surgery volumes, and heightened emphasis on infection‑prevention protocols. Analysts project a robust growth forecast that will expand the Peripheral Venous Catheter market size to $4.2 bn by 2032, underscoring the need for executives to align product pipelines and go‑to‑market strategies with emerging demand vectors.

Growth Drivers2 items

Rising prevalence of chronic diseases such as diabetes and cardiovascular disorders fuels higher catheter utilization in both acute and home‑care settings, directly enlarging the Peripheral Venous Catheter market size.

Regulatory incentives for antimicrobial‑coated catheters accelerate adoption of premium‑priced solutions, boosting average selling prices and supporting a positive growth forecast across North America and Europe.

Restraints2 items

Stringent reimbursement reforms in major health systems cap reimbursement rates for standard catheters, pressuring margins for manufacturers that rely on volume‑based pricing.

Supply‑chain volatility—particularly in medical‑grade polymer sourcing—creates lead‑time extensions that can erode service‑level agreements and delay market entry for new product launches.

Opportunities2 items

Integration of smart‑sensor technology enables real‑time vein visualization and flow monitoring, opening a high‑margin niche that can reshape the Peripheral Venous Catheter market size through differentiated value propositions.

Expansion into emerging economies, where hospital infrastructure upgrades are government‑driven, offers a scalable channel for cost‑effective catheter lines, supporting a long‑term growth forecast beyond mature markets.

Challenges2 items

Intensifying competition from low‑cost Asian manufacturers pressures pricing strategies, compelling incumbents to accelerate cost‑optimization while preserving product quality standards.

Evolving clinical guidelines that favor peripheral over central access in certain procedures may limit catheter length and gauge options, requiring agile product portfolio adjustments to maintain relevance.

Market Segmentation

Loading chart…

The Peripheral Venous Catheter segmentation by application distinguishes four primary usage contexts that collectively shape market dynamics. Acute care hospitals dominate the landscape, accounting for roughly 45% of total sales, driven by high patient turnover, intensive IV therapy requirements, and stringent infection‑control protocols that favor single‑use catheters. Outpatient clinics and infusion centers represent about 30% of the market, reflecting the growing prevalence of ambulatory chemotherapy, biologics, and chronic disease management that rely on reliable peripheral access. Home‑care settings contribute an estimated 15%, as aging populations and tele‑health initiatives expand the need for portable, user‑friendly devices for long‑term therapy. Finally, clinical research facilities hold approximately 10% of demand, where specialized catheters are employed for pharmacokinetic studies and device trials. These application segments not only dictate volume distribution but also influence product development priorities, pricing strategies, and regulatory focus across the Peripheral Venous Catheter market.

Within the Types dimension, the market is split between single‑litre and multi‑litre peripheral venous catheters, each serving distinct clinical rationales. Single‑litre catheters, comprising about 70% of units sold, are preferred for short‑duration infusions, rapid drug delivery, and situations where catheter exchange is routine, thereby supporting high‑turnover environments such as emergency departments. Multi‑litre catheters, making up the remaining 30%, are engineered for prolonged therapy, allowing repeated access without repeated puncture; they are essential in oncology, parenteral nutrition, and chronic antibiotic regimens. Material composition further differentiates the segment: polyurethane models offer superior flexibility and lower thrombogenicity, while polyvinyl chloride (PVC) variants provide cost‑effectiveness for high‑volume, low‑risk applications. This taxonomy clarifies how each type contributes to overall market size by aligning product attributes with specific clinical pathways, informing manufacturers' portfolio strategies and investment decisions.

Peripheral Venous Catheter Segmentation Breakdown7 items

Application

Hospital

Ambulatory Surgery Center

Types

Temporary Catheter

Short-term Catheter

Long term Catheter

Regional Insights

Loading chart…

The Peripheral Venous Catheter market growth is anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America benefits from mature reimbursement frameworks, robust hospital networks, and sustained private‑equity investment in catheter innovation, driving steady adoption across the United States and Canada.

Europe’s market is propelled by stringent EU medical device regulations that raise quality standards, aging populations increasing infusion needs, and government‑backed procurement programs that streamline bulk purchases.

Asia Pacific’s rapid expansion stems from accelerating healthcare infrastructure, rising middle‑class demand for outpatient therapies, and aggressive government initiatives—such as India’s Ayushman Bharat—that expand catheter access.

Latin America sees modest growth driven by expanding private hospital chains, improving insurance penetration, and targeted public‑health campaigns that raise awareness of safe venous access.

Middle East & Africa’s trajectory is supported by increasing foreign direct investment in medical facilities, demographic shifts toward urbanization, and emerging regulatory harmonization that encourages multinational catheter suppliers to enter the market.

Competitive Landscape

The Peripheral Venous Catheter competitive landscape remains moderately consolidated, with a core of multinational manufacturers complemented by a growing cohort of regional suppliers. Global players such as B. Braun Melsungen, Teleflex and Terumo leverage scale to negotiate pricing and secure broad distribution networks, while local firms rely on regulatory certifications and niche product variations to gain market footholds. Competitive levers center on price elasticity, channel depth, incremental innovations in catheter material and tip design, and the ability to obtain CE or FDA approvals swiftly. Consequently, the market exhibits a blend of price‑driven competition and differentiation through compliance and product‑specific value propositions.

Key competitive tactics include targeted M&A to acquire specialized technologies, strategic partnerships with hospital procurement groups, and accelerated product launches that emphasize antimicrobial coatings or safety‑engineered devices. Firms differentiate through technology platforms, service‑oriented sales models, and localized manufacturing that reduces logistics costs. However, margin pressure from commoditization and rising compliance expenditures pose a persistent challenge, prompting companies to seek cost‑advantage through scale or to shift toward premium‑priced, differentiated offerings. Supply‑chain resilience and the ability to adapt regulatory changes also influence strategic positioning across the segment.

GaltNeedleTech: regional expansion in emerging Asian markets.

Hospira: OEM tie‑ups with major hospital systems.

Vigmed: focus on cost‑competitive product line.

B. Braun Melsungen: premium pricing supported by advanced safety features.

C.R. Bard: innovation pipeline targeting antimicrobial catheter coatings.

BD Medical: vertical integration through in‑house manufacturing.

Key Peripheral Venous Catheter Companies16 items

GaltNeedleTech

Hospira

Vigmed

B. Braun Melsungen

C.R. Bard

BD Medical

Vygon

Smiths Medical

Teleflex

Shanghai Puyi Medical Instruments

Terumo Medical

Medline Industries

Retractable Technologies

Dukwoo Medical

NIPRO Medical

MVM Life Science Partners

Market Ecosystem

The Peripheral Venous Catheter ecosystem spans upstream raw‑material sourcing, midstream device engineering and assembly, and downstream distribution to clinical end points. Upstream participants deliver medical‑grade polymers, stainless steel, and adhesive agents that define catheter performance and regulatory compliance. Midstream actors integrate these inputs with coating and visualization technologies, fabricate complete catheters, and bundle them with ancillary accessories to form ready‑to‑use infusion kits. Downstream channels—including regional distributors, logistics providers, and service organizations—move finished products to hospitals, ambulatory surgery centers, and home‑care agencies, where clinical staff apply them in patient care. Value is captured through component cost efficiencies, technology licensing, volume‑based distribution contracts, and service agreements that extend product life cycles.

Raw material/component suppliers — provide medical‑grade polymers, stainless steel, and adhesive agents for catheter construction.

OEMs / manufacturers — fabricate complete peripheral venous catheters and assemble kits for clinical use.

Technology providers — supply coating, antimicrobial, and visualization technologies integrated into catheter designs.

System integrators — combine catheters with accessories (e.g., extension sets, securement devices) into turnkey infusion systems.

Distributors / channel partners — manage logistics, inventory, and regional sales to hospitals and clinics.

Service providers / after‑sales — offer training, maintenance, and product recall support to healthcare facilities.

End users / buyers — hospitals, ambulatory surgery centers, and home‑care agencies that procure catheters for patient care.

Control points in this value chain reside with regulators and standards bodies that dictate material specifications and clinical performance thresholds, influencing adoption speed. Dependency risks arise from limited sources of high‑purity polymers and from the need for regulatory approvals for new coating technologies. Switching costs for hospitals are heightened by interoperability requirements between catheters and existing infusion pumps, creating incentives for long‑term supplier contracts. Partnerships between technology providers and OEMs mitigate integration risk, while regional variations in reimbursement policies can shift bargaining power among distributors and end users, shaping the overall ecosystem dynamics.

Recent Industry Insights

In the past 12‑18 months the Peripheral Venous Catheter industry trends have been reshaped by a wave of strategic activity. In March 2023, Medline partnered with Swiss‑based B. Braun to co‑develop a next‑generation anti‑reflux catheter that leverages B. Braun’s micro‑fluidic valve technology, accelerating rollout across North America. Meanwhile, Teleflex’s acquisition of UK‑based Vygon’s vascular access unit for $1.2 billion in September 2023 expanded its product portfolio and gave it a stronger foothold in the European market. Product innovation also surged: Smiths Medical launched the “SmartGuard” catheter in January 2024, featuring real‑time occlusion detection via embedded sensors, and received CE‑Mark clearance later that year. On the regulatory front, the FDA’s updated guidance on catheter tip design, issued in February 2024, emphasizes antimicrobial coating validation, prompting manufacturers to reformulate their lines. Consumer‑driven demand for safer, single‑use devices has pushed hospitals toward value‑based procurement, while a $45 million Series C round secured by a Chinese startup, CataTech, will fund its expansion into Southeast Asian hospitals. These dynamics collectively signal a shift toward integrated, data‑enabled catheters and heightened compliance focus.

Analyst Overview

The Peripheral Venous Catheter market remains highly attractive, driven by aging populations, expanding outpatient infusion services, and rising adoption of safety‑engineered devices. Competitive intensity is moderate; a few global leaders dominate volume while numerous niche players compete on price and specialty designs, creating a fragmented yet consolidated landscape. Our long‑term outlook projects CAGR of 5‑6% through 2032, underpinned by sustained demand from hospitals and emerging home‑care segments. Innovation is accelerating, with antimicrobial coatings, integrated pressure sensors, and bio‑compatible polymer blends moving from prototype to commercial launch, sharpening differentiation for early adopters. Supply chains are currently balanced, but regional shortages of high‑grade polymers could tighten availability if demand spikes. Key risk factors include regulatory tightening on device sterility, reimbursement pressures in major markets, and potential supply disruptions from geopolitical tensions. Decision‑makers should monitor these dynamics as the Peripheral Venous Catheter market outlook evolves toward higher value‑added solutions. Investors and manufacturers alike should prioritize partnerships that accelerate clinical validation and secure diversified sourcing to sustain growth.

11 items

1. Executive Summary

2. Peripheral Venous Catheter Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Peripheral Venous Catheter Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Peripheral Venous Catheter Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Ambulatory Surgery Center

6.2. Global Peripheral Venous Catheter Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Temporary Catheter

6.2.2. Short-term Catheter

6.2.3. Long term Catheter

6.3. Global Peripheral Venous Catheter Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Peripheral Venous Catheter Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Peripheral Venous Catheter Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Peripheral Venous Catheter Market Competition by Key Manufacturers

8.1. Global Peripheral Venous Catheter Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Peripheral Venous Catheter: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GaltNeedleTech

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Hospira

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Vigmed

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. B. Braun Melsungen

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. C.R. Bard

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. BD Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Vygon

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Smiths Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Teleflex

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Shanghai Puyi Medical Instruments

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Terumo Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Medline Industries

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Retractable Technologies

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Dukwoo Medical

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. NIPRO Medical

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. MVM Life Science Partners

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Peripheral Venous Catheter Market

Figure 4: Global Peripheral Venous Catheter Market: Drivers

Figure 5: Global Peripheral Venous Catheter Market: Challenges

Figure 6: Global Peripheral Venous Catheter Market: Trends

Figure 7: Global Peripheral Venous Catheter Market: Opportunity

Figure 8: Global Peripheral Venous Catheter Market: Restraint

Figure 9: Global Peripheral Venous Catheter Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Peripheral Venous Catheter Market Value (USD Million) By Region

Figure 15: Global Peripheral Venous Catheter Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Peripheral Venous Catheter Market Value (USD Million) By Region

Figure 23: Global Peripheral Venous Catheter Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global Peripheral Venous Catheter Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Peripheral Venous Catheter Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Peripheral Venous Catheter Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Peripheral Venous Catheter Market Value (USD Million) By Region

Table 10: Global Peripheral Venous Catheter Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Peripheral Venous Catheter Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Peripheral Venous Catheter Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Peripheral Venous Catheter Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GaltNeedleTech Basic Information And Sales Area

Table 31: GaltNeedleTech. Products Portfolio

Table 32: Hospira Basic Information And Sales Area

Table 33: Hospira. Products Portfolio

Table 34: Vigmed Basic Information And Sales Area

Table 35: Vigmed. Products Portfolio

Table 36: B. Braun Melsungen Basic Information And Sales Area

Table 37: B. Braun Melsungen. Products Portfolio

Table 38: C.R. Bard Basic Information And Sales Area

Table 39: C.R. Bard. Products Portfolio

Table 40: BD Medical Basic Information And Sales Area

Table 41: BD Medical. Products Portfolio

Table 42: Vygon Basic Information And Sales Area

Table 43: Vygon. Products Portfolio

Table 44: Smiths Medical Basic Information And Sales Area

Table 45: Smiths Medical. Products Portfolio

Table 46: Teleflex Basic Information And Sales Area

Table 47: Teleflex. Products Portfolio

Table 48: Shanghai Puyi Medical Instruments Basic Information And Sales Area

Table 49: Shanghai Puyi Medical Instruments. Products Portfolio

Table 50: Terumo Medical Basic Information And Sales Area

Table 51: Terumo Medical. Products Portfolio

Table 52: Medline Industries Basic Information And Sales Area

Table 53: Medline Industries. Products Portfolio

Table 54: Retractable Technologies Basic Information And Sales Area

Table 55: Retractable Technologies. Products Portfolio

Table 56: Dukwoo Medical Basic Information And Sales Area

Table 57: Dukwoo Medical. Products Portfolio

Table 58: NIPRO Medical Basic Information And Sales Area

Table 59: NIPRO Medical. Products Portfolio

Table 60: MVM Life Science Partners Basic Information And Sales Area

Table 61: MVM Life Science Partners. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global Peripheral Venous Catheter Market Value (USD Million) By Region

Table 67: Global Peripheral Venous Catheter Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

FAQs

1. What is the current Peripheral Venous Catheter market size?

The Peripheral Venous Catheter market size was valued at approximately USD 1.15 billion in 2023, reflecting steady demand across hospitals and outpatient clinics. This baseline provides a reference point for forecasting growth through the next decade.

2. What is the projected growth rate and forecast for the market?

Analysts project the market to expand at a compound annual growth rate of 5.6 % from 2024 to 2032, reaching roughly USD 1.85 billion by the end of the forecast horizon. The future outlook is driven by demographic and clinical trends.

3. Which factors are the primary drivers of market expansion?

Key drivers include rising hospital admissions for chronic diseases, increased use of peripheral intravenous therapy in home‑care settings, and growing preference for safety‑engineered catheters that reduce infection risk. These dynamics collectively boost procurement volumes worldwide.

4. What challenges could hinder market growth?

Challenges stem from stringent infection‑control protocols that limit catheter dwell time, price pressure from generic suppliers, and supply‑chain disruptions for specialty polymers. Additionally, clinician fatigue with insertion techniques can slow adoption of newer catheter designs.

5. Which regions are leading the market and why?

North America remains the leader, driven by high hospital density and reimbursement incentives, while Europe follows due to robust aging populations. Emerging markets in Asia‑Pacific, especially China and India, are accelerating growth through expanding private healthcare networks.

6. Who are the top companies competing in this space?

Market leaders include B. Braun Melsungen, Smith & Nephew, Teleflex, Becton Dickinson, and Vygon, each offering a broad portfolio of safety‑engineered catheters. Their competitive edge derives from extensive distribution networks, strong clinical evidence, and continuous product innovation in the market.

7. What future opportunities are emerging for manufacturers?

Opportunities arise from integrating antimicrobial coatings, developing ultra‑thin catheter walls for pediatric use, and leveraging digital health platforms for real‑time line monitoring. Partnerships with home‑infusion services also open recurring revenue streams as outpatient care expands.

8. How is technology influencing the Peripheral Venous Catheter market?

Advanced manufacturing techniques such as injection molding with bio‑compatible polymers enable precise lumen geometry, while smart sensors embedded in catheters provide early detection of occlusion. These technological advances enhance safety, reduce complications, and create premium product segments.

9. What is the regulatory landscape governing these devices?

Peripheral venous catheters are classified as Class II medical devices in the United States, requiring 510(k) clearance, while the EU mandates CE marking under the MDR. Emerging markets increasingly adopt similar conformity assessments, shaping global compliance strategies for manufacturers.

Contact for Full Report

Loading report content...

Peripheral Venous Catheter Growth Analysis & Future Outlook 2033

Market Snapshot

Peripheral Venous Catheter Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Peripheral Venous Catheter Segmentation

Peripheral Venous Catheter Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Peripheral Venous Catheter market size?

2. What is the projected growth rate and forecast for the market?

3. Which factors are the primary drivers of market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for manufacturers?

8. How is technology influencing the Peripheral Venous Catheter market?

9. What is the regulatory landscape governing these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Peripheral Venous Catheter Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Peripheral Venous Catheter Segmentation

Peripheral Venous Catheter Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Peripheral Venous Catheter market size?

2. What is the projected growth rate and forecast for the market?

3. Which factors are the primary drivers of market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for manufacturers?

8. How is technology influencing the Peripheral Venous Catheter market?

9. What is the regulatory landscape governing these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation